Using three cohorts of human breast cancer data, they showed that one of the master regulator genes is ZNF695. Its expression differs depending on the tumor subtype – it is high in ER-negative subtypes (HER2-enriched and basal-like) and low in ER-positive (luminal tumors). This evidence concerns the gene ESR1 and neoplasm.